Cerep

155 Boulevard Haussmann
75008 Paris
France


Tel: +33 1 45 64 44 60
Fax: +33 1 45 64 44 64
Email Us

Print Email to a friend

Cerep has developed cutting edge technologies to provide its customers with a wide array of custom library synthesis solutions. Using our medicinal chemistry expertise, proprietary predictive models and modern parallel synthesis techniques, we can rapidly design and synthesize focused libraries around specific targets or scaffolds of interest. .Every compound is fully characterized and analyzed by LC/MS and a wide range of parallel purification techniques provide high purity standards. More than 30 focused libraries are available including a peptidomimetic library with 1000 compounds based on 28 building blocks.

Further Information: http://www.cerep.fr/cerep



Related news from our archive

Cerep Announces the Extension of its Pharmaco-Informatics Alliance with Pfizer
The goal of the collaboration is to provide early tools for in vitro safety evaluation of lead compounds.

Cerep Subsidiary, Hesperion, Acquires Touchstone Research Inc.
The acquisition of TouchStone Research will actively strengthen Hesperion’s North American coverage and service offerings.

Cerep and Servier Enter Collaboration Agreements
Cerep will apply its know-how and technologies in high-throughput screening and medicinal chemistry to identifiy moleculaes active on targets selcted by Servier.

Cerep Announces the Extension of its Pharmaco-Informatics Alliance with Pfizer
The goal of the collaboration is to provide early tools for in vitro safety evaluation of lead compounds.

Cerep Subsidiary, Hesperion, Acquires Touchstone Research Inc.
The acquisition of TouchStone Research will actively strengthen Hesperion’s North American coverage and service offerings.

Cerep and Servier Enter Collaboration Agreements
Cerep will apply its know-how and technologies in high-throughput screening and medicinal chemistry to identifiy moleculaes active on targets selcted by Servier.

Cerep enters into a multi-year pharmaco-informatics alliance with Pfizer